Factors associated with non–vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)-Reference-Cited by-同舟云学术

Factors associated with non–vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

Published:2017-07 Issue: Volume:189 Page:40-47
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Steinberg Benjamin A.^ORCID,Shrader Peter,Thomas Laine,Ansell Jack,Fonarow Gregg C.,Gersh Bernard J.,Hylek Elaine,Kowey Peter R.,Mahaffey Kenneth W.,O'Brien Emily C.,Singer Daniel E.,Peterson Eric D.,Piccini Jonathan P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

2. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

3. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

5. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimorbidity in atrial fibrillation for clinical implications using the Charlson Comorbidity Index;International Journal of Cardiology;2024-03

2. Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes ≥24 hours;European Heart Journal;2023-11-12

3. Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation;Journal of Thrombosis and Thrombolysis;2023-08-02

4. The influence of atrial high-rate episodes on stroke and cardiovascular death: an update;Europace;2023-06-22

5. Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era;IJC Heart & Vasculature;2023-06